325 related articles for article (PubMed ID: 35163563)
1. Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications.
Lakshmi BA; Kim YJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163563
[TBL] [Abstract][Full Text] [Related]
2. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood-Brain Barrier.
Song X; Qian H; Yu Y
Small; 2023 Nov; 19(45):e2302613. PubMed ID: 37415556
[TBL] [Abstract][Full Text] [Related]
4. Immunoengineering in glioblastoma imaging and therapy.
Zanganeh S; Georgala P; Corbo C; Arabi L; Ho JQ; Javdani N; Sepand MR; Cruickshank K; Campesato LF; Weng CH; Hemayat S; Andreou C; Alvim R; Hutter G; Rafat M; Mahmoudi M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1575. PubMed ID: 31407522
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme.
Yao J; Hsu CH; Li Z; Kim TS; Hwang LP; Lin YC; Lin YY
Curr Pharm Des; 2015; 21(36):5256-66. PubMed ID: 26412354
[TBL] [Abstract][Full Text] [Related]
6. Nanoformulations for glioblastoma multiforme: a new hope for treatment.
Ortiz R; Cabeza L; Perazzoli G; Jimenez-Lopez J; García-Pinel B; Melguizo C; Prados J
Future Med Chem; 2019 Sep; 11(18):2459-2480. PubMed ID: 31544490
[TBL] [Abstract][Full Text] [Related]
7. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
Hadjipanayis CG; Machaidze R; Kaluzova M; Wang L; Schuette AJ; Chen H; Wu X; Mao H
Cancer Res; 2010 Aug; 70(15):6303-12. PubMed ID: 20647323
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology applications for glioblastoma.
Nduom EK; Bouras A; Kaluzova M; Hadjipanayis CG
Neurosurg Clin N Am; 2012 Jul; 23(3):439-49. PubMed ID: 22748656
[TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
[TBL] [Abstract][Full Text] [Related]
10. Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.
Shevtsov M; Multhoff G
Curr Drug Metab; 2016; 17(8):737-744. PubMed ID: 27280470
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
[TBL] [Abstract][Full Text] [Related]
12. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
Hassanzadeh P; Atyabi F; Dinarvand R
Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
[TBL] [Abstract][Full Text] [Related]
13. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
[TBL] [Abstract][Full Text] [Related]
14. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.
Wankhede M; Bouras A; Kaluzova M; Hadjipanayis CG
Expert Rev Clin Pharmacol; 2012 Mar; 5(2):173-86. PubMed ID: 22390560
[TBL] [Abstract][Full Text] [Related]
15. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.
Sonali ; Singh RP; Singh N; Sharma G; Vijayakumar MR; Koch B; Singh S; Singh U; Dash D; Pandey BL; Muthu MS
Drug Deliv; 2016 May; 23(4):1261-71. PubMed ID: 26961144
[TBL] [Abstract][Full Text] [Related]
16. Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles.
Daldrup-Link HE
Mol Imaging; 2017; 16():1536012117730950. PubMed ID: 28929923
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
18. Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment
Yang J; Shi Z; Liu R; Wu Y; Zhang X
Theranostics; 2020; 10(7):3223-3239. PubMed ID: 32194864
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
20. An Advanced
Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
